Publikationen von F. Holsboer

Wetter, T. C.; Wehrle, R.; Kaufmann, C.; Auer, D. P.; Holsboer, F.; Pollmächer, T.; Czisch, M.: Processing of acoustic stimuli during NREM sleep: Results from a simultaneous FMRI and EEG study. Sleep 26, S. A54 - A55 (2003)

Murck, H.; Held, K.; Ziegenbein, M.; Künzel, H.; Holsboer, F.; Steiger, A.: The neuropeptide galanin increases rem latency and alleviates depressed mood in patients with depression. Biological Psychiatry 53 (8 Suppl. Suppl. S), S. 131S - 131S (2003)

Modell, S.; Huber, J.; Holsboer, F.; Lauer, C. J.: The Munich vulnerability study on affective disorders: risk factors for unipolarity versus bipolarity. Journal of Affective Disorders 74 (2), S. 173 - 184 (2003)

Nickel, T.; Sonntag, A.; Schill, J.; Zobel, A. W.; Ackl, N.; Brunnauer, A.; Murck, H.; Ising, M.; Yassouridis, A.; Steiger, A. et al.; Zihl, J.; Holsboer, F.: Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology 23 (2), S. 155 - 168 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Uhr, M.; Ohl, F.; Wigger, A.; Toschi, N.; Holsboer, F.; Landgraf, R.: Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28 (2), S. 235 - 243 (2003)

Murck, H.; Nickel, T.; Künzel, H.; Antonijevic, I. A.; Schill, J.; Zobel, A.; Steiger, A.; Sonntag, A.; Holsboer, F.: State markers of depression in sleep EEG: Dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology 28 (2), S. 348 - 358 (2003)

Bachmann, C. G.; Linthorst, A. C.E.; Holsboer, F.; Reul, J. M. H. M.: Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis. Neuropsychopharmacology 28, S. 1056 - 1067 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Molecular Psychiatry 8 (12), S. 994 - 1007 (2003)

Holsboer, F.: Corticotropin-releasing hormone modulators and depression. Current Opinion in Investigational Drugs 4 (1), S. 46 - 50 (2003)

Holsboer, F.: The role of peptides in treatment of psychiatric disorders. Journal of Neural Transmission-Supplement (64), S. 17 - 34 (2003)

Holsboer, F.: High-Quality Antidepressant Discovery by Understanding Stress Hormone Physiology. Annals of the New York Academy of Sciences 1007, S. 394 - 404 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Landgraf, R.; Holsboer, F.: The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry 36 (1), S. 27 - 31 (2003)

Mitev, A.; Darwish, M.; Wolf, S.; Holsboer, F.; Almeida, O. F. X.; Patchev, V.: Gender differences in the regulation of 3α-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress protection. Neuroscience 120 (2), S. 541 - 549 (2003)

Müller, M. B.; Keck, M. E.; Binder, E. B.; Kresse, A. E.; Hagemeyer, T. P.; Landgraf, R.; Holsboer, F.; Uhr, M.: ABCBI (MDRI)- type P-Glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 28 (11), S. 1991 - 1999 (2003)

Müller, M. B.; Zimmermann, S.; Sillaber, I.; Hagemeyer, T. P.; Deussing, J. M.; Timpl, P.; Kormann, M. S. D.; Droste, S. K.; Kühn, R.; Reul, J. M. H. M. et al.; Holsboer, F.; Wurst, W.: Limbic corticotropin-releasing hormone receptor I mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience 6 (10), S. 1100 - 1107 (2003)

Oshima, A.; Flachskamm, C.; Reul, J. M.H.M.; Holsboer, F.; Linthorst, A. C. E.: Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type I antagonist NBI 30775. Neuropsychopharmacology 28 (12), S. 2148 - 2159 (2003)

Peñalva, R. G.; Lancel, M.; Flachskam, C.; Reul, J. M. H. M.; Holsboer, F.; Linthorst, A. C. E.: Effect of sleep and sleep deprivation on serotonergic neurotransmission in the hippocampus: a combined in vivo microdialysis/EEG study in rats. European Journal of Neuroscience 17 (9), S. 1896 - 1906 (2003)

Refojo, D.; Liberman, A. C.; Giacomini, D.; Nagashima, A. C.; Graciarena, M.; Echenique, C.; Pereda, M. P.; Stalla, G.; Holsboer, F.; Arzt, E.: Integrating systemic information at the molecular level - Cross-talk between steroid receptors and cytokine signaling on different target cells. Neuroendocrine and neural regulation of autoimmune and inflammatory disease: molecular systems and clinical insights, S. 196 - 204 (2003)

Rosenhagen, M. C.; Sõti, C.; Schmidt, U.; Wochnik, G. M.; Hartl, F. U.; Holsboer, F.; Young, J. C.; Rein, T.: The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation. Molecular Endocrinology 17 (10), S. 1991 - 2001 (2003)

Schmidt, M.; Oitzl, M. S.; Müller, M. B.; Ohl, F.; Wurst, W.; Holsboer, F.; Levine, S.; De Kloet, E. R.: Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice. Neuroscience 119 (2), S. 589 - 595 (2003)